India Pharmaceutical Market
"Indian pharmaceutical industry stands at the third spot in terms of volume and at the fourteenth in terms of value". Its total turnover stood at US$ 21 billion, growing at a CAGR of 12% in 2009. With No doubts, Indian Pharmaceutical Industry is growing like never before and thus, offers huge investment opportunities for both domestic and foreign Companies.

Major attractions for Foreign Companies

  • High Domestic Consumption – With a rise in the population of high-income generating group, India is emerging as a lucrative destination for foreign companies. Domestic Pharmaceutical Consumption estimated to be US $ 7.3 Billion in 2009, growing at 13% year on year.
  • Innovative Product Development – Global Players looking at Collaborative Research with India Companies. Indian pharmaceutical R&D expenditure in absolute terms stands at US$ 660 million.
  • Contract Manufacturing – The demand for contract manufacturing of Formulations, API & Intermediates is estimated to be around US $ 1.1 Billion by 2010.
  • Clinical Trial Outsourcing –. Clinical trials market currently stands at US$ 275 million, growing at a CAGR of 30% over last few years.

Incentive for Foreign Companies

  • Strong Domestic Market for Global Players for Introducing their High Quality International Standard Products.
  • Cost-Efficiency: Pharmaceutical market in India is highly fragmented with over 8,000 manufacturers. Indian Companies can manufacture pharmaceutical for less than half the cost than US.
  • Clinical Trial Outsourcing - The variety of Gene Pool, Large number of diseases, English speaking physicians and support staff and therapy naïve patients – make India as an attractive destination for Clinical Trial Outsourcing.
  • Strong Technical Capability: At present, India boasts of 119 USFDA & 84 UKMHRA approved plants. Above mentioned sites demonstrate the ability if Indian companies to deliver high quality products.
  • Innovative Product Development – the growing R&D pipeline of Indian Companies presents significant in-licensing opportunities for global companies.
  • Government Support
    • Indian government is committed to harness India’s innovation capability and is embarking on a multi-billion dollar public-private partnership models.
    • 100% Foreign Direct Investment is allowed under automatic route in pharmaceutical sector.
  • Introduction of product patents has renewed the interest of formerly cautious big pharma in India.
  • There are 19 dedicated SEZ’s in various stages of development.


The drug and pharmaceutical sector saw a cumulative FDI inflow worth US$ 1.7 billion from the period of April 2000 to January 2010.

How We Can Help?

At CO Globe, we understand how competitive the market is and thus, believe in providing a complete new source of competitive-edge for our clients. With in-house teams of professional analysts and market experts, we enable our clients make informed decision-making. We adopts a collaborative approach to every project so as to offer the customized solutions that reflect a deep understanding of your business and let you move forward with ease.

© Copyright 2011 CO GLOBE. All Rights Reserved.